Innovative Israeli cell therapy could step up treatment of CLI.
Lars Norgren, emeritus professor at Örebro University in Sweden, and a member of the CLI study steering committee; Prof. Nikol Sigrid senior consultant of the Department of Clinical and Interventional Angiology at the St. Georg Asklepios Hospital in Hamburg, Germany and Pluristem co-CEO Zami Aberman(photo credit: Courtesy)ByMAAYAN HOFFMAN
